Inside PBM Reform: Big Pharma’s Big Win on “Delinking”

In the years-long debate over pharmacy benefit manager (PBM) legislation that culminated with landmark reform enacted in the Consolidated Appropriations Act (CAA), one policy change stands out. It’s not increased transparency, no, PBMs were on track to give employers every bit of information requested, and more. It’s not the rebate pass-through provision because PBMs are already passing through nearly 100% of rebates to employers. Dubbed “delinking” and sold by Big Pharma in a bag of goods to Congress, the policy is a Trojan Horse that will […]